validated shard 369
Browse files
validated/shard_00369.jsonl
ADDED
|
@@ -0,0 +1,4 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{"session_id": "atlas-8bf3d89af6", "tier": "text", "task_instruction": "Determine the cure rate for different leukemia types based on the passage.", "source": "llm_generated", "grounded_in": "wikitext-103", "steps": [{"step_index": 0, "observation": {"text": "The passage discusses cure rates in clinical trials for AML and promyelocytic leukemia.", "image_path": null, "audio_path": null}, "reasoning": "Clinical trials often have higher cure rates because they include healthier, younger participants who can tolerate aggressive treatments.", "action": {"type": "text_response", "value": "Identify the specific cure rate figures provided for each leukemia type."}, "refers_back_to": null}, {"step_index": 1, "observation": {"text": "The cure rate for AML in clinical trials is 20–45%, but this might be higher for other types.", "image_path": null, "audio_path": null}, "reasoning": "However, the overall cure rate for all AML patients, including the elderly and those who can't handle aggressive therapy, is likely lower than the clinical trial rates.", "action": {"type": "text_response", "value": "Note that the overall cure rate for AML is lower than the trial rates."}, "refers_back_to": null}, {"step_index": 2, "observation": {"text": "Promyelocytic leukemia has a much higher cure rate.", "image_path": null, "audio_path": null}, "reasoning": "The passage states that cure rates for promyelocytic leukemia can be as high as 98%.", "action": {"type": "text_response", "value": "Record the 98% cure rate for promyelocytic leukemia."}, "refers_back_to": null}, {"step_index": 3, "observation": {"text": "AML cure rates in clinical trials are 20–45%, but the overall rate is lower.", "image_path": null, "audio_path": null}, "reasoning": "Therefore, the cure rates for different leukemia types are as follows: AML has 20–45% in trials and likely lower overall, while promyelocytic leukemia has a 98% cure rate.", "action": {"type": "text_response", "value": "Summarize the cure rates for each leukemia type."}, "refers_back_to": null}], "task_complexity": "high", "language": "en", "license": "CC-BY-SA-3.0", "date_created": "2026-08-18", "_structural_pass": true, "_structural_reason": "ok", "_repaired": false, "_seed_type": "wikitext", "_seed_content": "Cure rates in clinical trials have ranged from 20 – 45 % ; although clinical trials often include only younger people and those able to tolerate aggressive therapies . The overall cure rate for all people with AML ( including the elderly and those unable to tolerate aggressive therapy ) is likely lower . Cure rates for promyelocytic leukemia can be as high as 98 % .", "_validation_note": "Reasoning is logical, response is correct, and it's coherent."}
|
| 2 |
+
{"session_id": "atlas-8b72fe3cac", "tier": "text", "task_instruction": "Determine the annual number of new AML cases in the United States based on the passage.", "source": "llm_generated", "grounded_in": "wikitext-103", "steps": [{"step_index": 0, "observation": {"text": "The passage mentions there are approximately 10 to 500 new cases each year in the United States.", "image_path": null, "audio_path": null}, "reasoning": "I need to calculate the annual number of new AML cases using the provided range.", "action": {"type": "text_response", "value": "Since the passage gives a range, the exact number isn't specified, so I'll state that the annual number falls between 10 and 500 cases."}, "refers_back_to": null}, {"step_index": 1, "observation": {"text": "The incidence rate has remained stable from 1995 through 2005.", "image_path": null, "audio_path": null}, "reasoning": "This indicates that the number of cases each year hasn't fluctuated much over this period.", "action": {"type": "text_response", "value": "Therefore, the annual number of new AML cases remains consistently between 10 and 500 each year in the U.S."}, "refers_back_to": null}], "task_complexity": "low", "language": "en", "license": "CC-BY-SA-3.0", "date_created": "2026-08-18", "_structural_pass": true, "_structural_reason": "ok", "_repaired": false, "_seed_type": "wikitext", "_seed_content": "Acute myeloid leukemia is a relatively rare cancer . There are approximately 10 @,@ 500 new cases each year in the United States , and the incidence rate has remained stable from 1995 through 2005 . AML accounts for 1 @.@ 2 % of all cancer deaths in the United States .", "_validation_note": "<reason>"}
|
| 3 |
+
{"session_id": "atlas-33a4e8591e", "tier": "text", "task_instruction": "Analyze the factors contributing to the incidence of AML and their demographic implications.", "source": "llm_generated", "grounded_in": "wikitext-103", "steps": [{"step_index": 0, "observation": {"text": "AML incidence rises with age, with a median diagnosis at 63 years.", "image_path": null, "audio_path": null}, "reasoning": "This shows that age is a major factor in AML development. As people age, their bodies become more prone to diseases like blood cancers, including AML.", "action": {"type": "text_response", "value": "Investigate age-related risk factors in AML."}, "refers_back_to": null}, {"step_index": 1, "observation": {"text": "AML is prevalent in adults, making up 90% of acute leukemias, while rare in children.", "image_path": null, "audio_path": null}, "reasoning": "This indicates AML mainly affects adults, especially those over 63. Children are less affected, so adult demographics are crucial for incidence studies.", "action": {"type": "text_response", "value": "Focus on adult demographics in AML incidence analysis."}, "refers_back_to": null}, {"step_index": 2, "observation": {"text": "Therapy-related AML is increasing, now 10-20% of cases.", "image_path": null, "audio_path": null}, "reasoning": "The rise in therapy-related AML points to prior chemotherapy as a significant contributing factor. This means individuals with a history of chemo are at higher risk for AML later in life.", "action": {"type": "text_response", "value": "Study the impact of prior chemotherapy on AML incidence."}, "refers_back_to": null}, {"step_index": 3, "observation": {"text": "AML is more common in men, with a male-to-female ratio of 1.3:1.", "image_path": null, "audio_path": null}, "reasoning": "This sex-based disparity suggests biological or genetic factors may make men more susceptible. Understanding these could help in targeted prevention and treatment strategies.", "action": {"type": "text_response", "value": "Explore biological and genetic factors in AML susceptibility among men."}, "refers_back_to": null}], "task_complexity": "high", "language": "en", "license": "CC-BY-SA-3.0", "date_created": "2026-08-18", "_structural_pass": true, "_structural_reason": "ok", "_repaired": false, "_seed_type": "wikitext", "_seed_content": "The incidence of AML increases with age ; the median age at diagnosis is 63 years . AML accounts for about 90 % of all acute leukemias in adults , but is rare in children . The rate of therapy @-@ related AML ( that is , AML caused by previous chemotherapy ) is rising ; therapy @-@ related disease currently accounts for about 10 – 20 % of all cases of AML . AML is slightly more common in men , with a male @-@ to @-@ female ratio of 1 @.@ 3 : 1 .", "_validation_note": "<reason>"}
|
| 4 |
+
{"session_id": "atlas-705efe01bf", "tier": "text", "task_instruction": "Identify the key observations and terms related to the early descriptions of leukemia in the passage.", "source": "llm_generated", "grounded_in": "wikitext-103", "steps": [{"step_index": 0, "observation": {"text": "The passage mentions that Alfred Armand Louis Marie Velpeau described a case of leukemia in 1827.", "image_path": null, "audio_path": null}, "reasoning": "This suggests that Velpeau was one of the first to document leukemia, noting symptoms like fever and changes in blood consistency.", "action": {"type": "text_response", "value": "Identify Velpeau as the first to describe leukemia with specific symptoms."}, "refers_back_to": null}, {"step_index": 1, "observation": {"text": "Velpeau noted the blood had a consistency like gruel and attributed it to white corpuscles.", "image_path": null, "audio_path": null}, "reasoning": "This indicates he observed a connection between blood changes and an overabundance of white blood cells, a hallmark of leukemia.", "action": {"type": "text_response", "value": "Recognize Velpeau's observation of blood abnormalities linked to white corpuscles."}, "refers_back_to": null}, {"step_index": 2, "observation": {"text": "In 1845, J.H. Bennett reported cases with enlarged spleens and blood changes, using the term 'leucocythemia'.", "image_path": null, "audio_path": null}, "reasoning": "This shows that by the mid-19th century, the condition was being recognized and named, though terminology may have evolved.", "action": {"type": "text_response", "value": "Identify Bennett's contribution to the understanding and naming of leukemia."}, "refers_back_to": null}], "task_complexity": "low", "language": "en", "license": "CC-BY-SA-3.0", "date_created": "2026-08-18", "_structural_pass": true, "_structural_reason": "ok", "_repaired": false, "_seed_type": "wikitext", "_seed_content": "The first published description of a case of leukemia in medical literature dates to 1827 , when French physician Alfred @-@ Armand @-@ Louis @-@ Marie Velpeau described a 63 @-@ year @-@ old florist who developed an illness characterized by fever , weakness , urinary stones , and substantial enlargement of the liver and spleen . Velpeau noted the blood of this person had a consistency \" like gruel \" , and speculated the appearance of the blood was due to white corpuscles . In 1845 , a series of people who died with enlarged spleens and changes in the \" colors and consistencies of their blood \" was reported by the Edinburgh @-@ based pathologist J.H. Bennett ; he used the term \" leucocythemia \" to describe this pathological condition .", "_validation_note": "[reason]"}
|